ERJ Express. Published on June 25, 2015 as doi: 10.1183/09031936.00219214 TASK FORCE REPORT ERS STATEMENT ERS task force statement: diagnosis and treatment of primary spontaneous pneumothorax Jean-Marie Tschopp1,13, Oliver Bintcliffe2, Philippe Astoul3, Emilio Canalis4, Peter Driesen5, Julius Janssen6, Marc Krasnik7, Nicholas Maskell2, Paul Van Schil8, Thomy Tonia9, David A. Waller10, Charles-Hugo Marquette11 and Giuseppe Cardillo12,13 Affiliations: 1Centre Valaisan de Pneumologie, Dept of Internal Medicine RSV, Montana, Switzerland. 2Academic Respiratory Unit, School of Clinical Sciences, University of Bristol, Bristol, UK. 3Dept of Thoracic Oncology, Pleural Diseases and Interventional Pulmonology, Hospital North Aix-Marseille University, Marseille, France. 4Dept of Surgery, University of Rovira I Virgili, Tarragona, Spain. 5Dept of Pneumology, AZ Turnhout, Turnhout, Belgium. 6Dept of Pulmonary Diseases, Canisius Wilhelmina Hospital, Nijmegen, The Netherlands. 7Dept of Cardiothoracic Surgery, Rigshospitalet, Copenhagen, Denmark. 8Dept of Thoracic and Vascular Surgery, Antwerp University Hospital, Antwerp, Belgium. 9Institute of Social and Preventative Medicine, University of Bern, Bern, Switzerland. 10Dept of Thoracic Surgery, Glenfield Hospital, Leicester, UK. 11Hospital Pasteur CHU Nice and Institute for Research on Cancer and Ageing, University of Nice Sophia Antipolis, Nice, France. 12Dept of Thoracic Surgery, Carlo Forlanini Hospital, Azienda Ospedaliera San Camillo Forlanini, Rome, Italy. 13Task Force Chairs. Correspondence: Jean-Marie Tschopp, Centre Valaisan de Pneumologie, 3963 Montana, Switzerland. E-mail:
[email protected] ABSTRACT Primary spontaneous pneumothorax (PSP) affects young healthy people with a significant recurrence rate. Recent advances in treatment have been variably implemented in clinical practice. This statement reviews the latest developments and concepts to improve clinical management and stimulate further research.